In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...